The Fact About ABBV-744 in combination with immunotherapy That No One Is Suggesting
In Segment C, individuals will acquire ABBV-744 and oral navitoclax. In Segment D, members will acquire ABBV-744 and ruxolitinib. Individuals will get treatment right until disease progression or perhaps the contributors are not able to tolerate the study drugs.Ubiquitin-relevant proteins that regulate The soundness of key super enhancer-mediated p